Volume 65, Issue 2 pp. 167-175
Original Article

A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: Seizure response, adverse events, and verbal memory

Nicholas M. Barbaro MD

Corresponding Author

Nicholas M. Barbaro MD

Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA

Department of Neurology, University of California at San Francisco, San Francisco, CA

Box 0112 UCSF Neurosurgery, 505 Parnassus Avenue, San Francisco, CA 94143Search for more papers by this author
Mark Quigg MD, MSc

Mark Quigg MD, MSc

Department of Neurology, University of Virginia, Charlottesville, VA

Search for more papers by this author
Donna K. Broshek PhD

Donna K. Broshek PhD

Department of Behavioral Medicine, University of Virginia, Charlottesville, VA

Search for more papers by this author
Mariann M. Ward RN, NP

Mariann M. Ward RN, NP

Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
Kathleen R. Lamborn PhD

Kathleen R. Lamborn PhD

Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
Kenneth D. Laxer MD

Kenneth D. Laxer MD

Pacific Epilepsy Program, California Pacific Medical Center

Search for more papers by this author
David A. Larson PhD, MD

David A. Larson PhD, MD

Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
William Dillon MD

William Dillon MD

Department of Radiology, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
Lynn Verhey PhD

Lynn Verhey PhD

Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
Paul Garcia MD

Paul Garcia MD

Department of Neurology, University of California at San Francisco, San Francisco, CA

Search for more papers by this author
Ladislau Steiner MD, PhD

Ladislau Steiner MD, PhD

Department of Neurological Surgery, University of Virginia, Charlottesville, VA

Search for more papers by this author
Christine Heck MD

Christine Heck MD

Department of Neurology, University of Southern California, Los Angeles, CA

Search for more papers by this author
Douglas Kondziolka MD, MSc

Douglas Kondziolka MD, MSc

University of Pittsburgh, Pittsburgh, PA

Search for more papers by this author
Robert Beach MD

Robert Beach MD

State University of New York, Upstate Medical Center, Syracuse, NY

Search for more papers by this author
William Olivero MD

William Olivero MD

Illinois Neurological Institute, Peoria, IL

Search for more papers by this author
Thomas C. Witt MD

Thomas C. Witt MD

Department of Neurological Surgery, Indiana University, Indianapolis, IN

Search for more papers by this author
Vicenta Salanova MD

Vicenta Salanova MD

Department of Neurology, Indiana University, Indianapolis, IN

Search for more papers by this author
Robert Goodman MD

Robert Goodman MD

Columbia University, New York, NY

Search for more papers by this author
First published: 25 February 2009
Citations: 145

Potential conflict of interest: D. Kondziolka is a paid consultant for Elekta, AB.

Abstract

Objective

The safety, efficacy, and morbidity of radiosurgery (RS) must be established before it can be offered as an alternative to open surgery for unilateral mesial temporal lobe epilepsy. We report the 3-year outcomes of a multicenter, prospective pilot study of RS.

Methods

RS was randomized to 20 or 24Gy targeting the amygdala, hippocampus, and parahippocampal gyrus. Seizure diaries evaluated the final seizure remission between months 24 and 36. Verbal memory was evaluated at baseline and 24m with the Wechsler Memory Scale–Revised (WMS-R) and California Verbal Learning Test (CVLT). Patients were classified as having “significant improvement,” “no change,” and “significant impairment” based on relative change indices.

Results

Thirteen high-dose and 17 low-dose patients were treated. Both groups showed significant reductions in seizures by 1 year after treatment. At the 36-month follow-up evaluation, 67% of patients were free of seizures for the prior 12 months (high dose: 10/13, 76.9%; low dose: 10/17, 58.8%). Use of steroids, headaches, and visual field defects did not differ by dose or seizure remission. The prevalence of verbal memory impairment was 15% (4/26 patients); none declined on more than one measure. The prevalence of significant verbal memory improvements was 12% (3/26).

Interpretation

RS for unilateral mesial temporal lobe epilepsy offers seizure remission rates comparable with those reported previously for open surgery. There were no major safety concerns with high-dose RS compared with low-dose RS. Additional research is required to determine whether RS may be a treatment option for some patients with mesial temporal lobe epilepsy. Ann Neurol 2009

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me